The Edmonton Symptom Assessment System (ESAS) as a Screening Tool for Depression in Cancer Pain Patients
NCT ID: NCT03686605
Last Updated: 2022-07-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
49 participants
OBSERVATIONAL
2018-09-24
2020-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Edmonton Symptom Assessment Scale: Self-Completion vs. Assisted-Completion
NCT02523378
Psychometric Validation of the ESAS12-F
NCT04076267
The Impact of a Patient Education Intervention for Ambulatory Oncology Patients
NCT02038114
New Assessment System in Measuring Symptom Distress in Cancer Patients
NCT00505245
Effects of Mirtazapine on Appetite in Advanced Cancer Patients
NCT00488072
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cancer pain patients
Thai version of the Edmontom Symptom Assessment System (ESAS)
Screening and diagnostic questionaire for depression
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Thai version of the Edmontom Symptom Assessment System (ESAS)
Screening and diagnostic questionaire for depression
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age older than 18 years old
* Fluently read, write and speak in Thai language
* No cognitive impairment
Exclusion Criteria
* Severe pain or pain numerical rating scale more than 7
* Severe associated symptoms such as nausea, vomiting
* The patient who do not know their diagnosis
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mahidol University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Suratsawadee Wangnamthip
Lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Suratsawadee Wangnamthip, MD
Role: PRINCIPAL_INVESTIGATOR
Lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of medicine Siriraj Hospital Mahidol University
Bangkoknoi, Bangkok, Thailand
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Si 276/2018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.